SCHEMBL7055148

SCHEMBL7055148

NCCC(Oc1ccccc1I)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.55
SLC6A4 P31645 10/20 0.50
CYP2D6 P10635 8/20 0.50
NOS2 P35228 6/20 0.50
SLC6A3 Q01959 5/20 0.50
KCNH2 Q12809 3/20 0.50
KCNK2 O95069 1/20 0.50
CACNA1C Q13936 1/20 0.50
HRH1 P35367 3/20 0.46
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 4/20 0.44
TSHR P16473 3/20 0.44
KMT2A Q03164 2/20 0.44
CHRM1 P11229 2/20 0.44
ADRA2B P18089 2/20 0.44
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44
OPRM1 P35372 2/20 0.44
DRD3 P35462 2/20 0.44
OPRK1 P41145 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9983096 0.83 SLC6A2 (0.44) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL9293469 0.83 SLC6A2 (0.44) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL7052799 0.81 SLC6A2 (0.56) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL5397302 0.80 SLC6A2 (0.58) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL4624371 0.80 SLC6A2 (0.68) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL2212613 0.80 SLC6A2 (0.68) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL7055269 0.80 SLC6A2 (0.58) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL5306302 0.80 SLC6A2 (0.68) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL5445187 0.80 SLC6A2 (0.55) SLC6A2SLC6A4CYP2D6NOS2SLC6A3
SCHEMBL2633864 0.80 SLC6A2 (0.68) SLC6A2SLC6A4CYP2D6NOS2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP disclosed